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Surface proteins of Staphylococcus aureus are an-
chored to the cell wall peptidoglycan by a mechanism
requiring a C-terminal sorting signal with an LPXTG
motif. Surface proteins are first synthesized in the bac-
terial cytoplasm and then transported across the cyto-
plasmic membrane. Cleavage of the N-terminal signal
peptide of the cytoplasmic surface protein P1 precursor
generates the extracellular P2 species, which is the sub-
strate for the cell wall anchoring reaction. Sortase, a
membrane-anchored transpeptidase, cleaves P2 be-
tween the threonine (T) and the glycine (G) of the
LPXTG motif and catalyzes the formation of an amide
bond between the carboxyl group of threonine and the
amino group of cell wall cross-bridges. We have used
metabolic labeling of staphylococcal cultures with
[32P]phosphoric acid to reveal a P3 intermediate. The
32P-label of immunoprecipitated surface protein is re-
moved by treatment with lysostaphin, a glycyl-glycine
endopeptidase that separates the cell wall anchor struc-
ture. Furthermore, the appearance of P3 is prevented in
the absence of sortase or by the inhibition of cell wall
synthesis. 32P-Labeled cell wall anchor species bind to
nisin, an antibiotic that is known to form a complex with
lipid II. Thus, it appears that the P3 intermediate rep-
resents surface protein linked to the lipid II peptidogly-
can precursor. The data support a model whereby lipid
II-linked polypeptides are incorporated into the grow-
ing peptidoglycan via the transpeptidation and trans-
glycosylation reactions of cell wall synthesis, generating
mature cell wall-linked surface protein.
To mount a successful infection, Gram-positive pathogens
display proteins on the bacterial surface that adhere to specific
receptors on host tissues or provide for microbial escape from
the host’s immune response (1). Protein display on the bacterial
surface involves the covalent linkage of polypeptides to the cell
wall envelope (2). As reported for protein A of Staphylococcus
aureus, surface proteins are synthesized as P1 precursor mol-
ecules in the bacterial cytoplasm, bearing an N-terminal signal
peptide and a C-terminal sorting signal (3). The 35-residue
sorting signal is composed of a LPXTG motif, a hydrophobic
domain, and a tail of positively charged residues (4). After
translocation across the cytoplasmic membrane, the N-termi-
nal signal peptide is removed by signal peptidase, thereby
generating the P2 precursor (4). The C-terminal sorting signal
retains the P2 precursor species within the secretory pathway
and permits substrate recognition at the LPXTG motif (4, 5).
Sortase, a membrane-anchored transpeptidase, cleaves surface
proteins between the threonine (T) and the glycine (G) of the
LPXTG motif (6, 7). Cleaved polypeptides are initially tethered
as thioester-linked intermediates to the active site sulfhydryl
residue of sortase enzymes (8). Nucleophilic attack of the amino
group of pentaglycine cross-bridges within the staphylococcal
peptidoglycan resolves this acyl-enzyme intermediate (8), re-
sulting in the formation of an amide bond that tethers the C
terminus of surface protein to the cell wall peptidoglycan
(9–13).
The peptidoglycan of S. aureus is synthesized in three cellu-
lar compartments, the cytoplasm, the membrane and the cell
wall envelope (14). The soluble cytoplasmic peptidoglycan pre-
cursor UDP-MurNAc-L-Ala-D-iGln-L-Lys-D-Ala-D-Ala1 (Park’s
nucleotide) is linked to the membrane lipid undecaprenolphos-
phate, generating lipid I (undecaprenolpyrophosphate-Mur-
NAc-L-Ala-D-iGln-(NH2)-L-Lys-D-Ala-D-Ala) (15–17). Lipid I is
modified by the addition of GlcNAc and pentaglycine to yield
lipid II (undecaprenolpyrophosphate-MurNAc(-L-Ala-D-iGln-
(NH2-Gly5)-L-Lys-D-Ala-D-Ala)-(1–4)-GlcNAc) (18, 19). Lipid
II is translocated across the cytoplasmic membrane and func-
tions as a substrate for two cell wall biosynthetic reactions that
require mono- or bifunctional transglycosylases and transpep-
tidases (20). In the transglycosylation reaction, lipid II is poly-
merized to generate linear peptidoglycan strands with the re-
peating disaccharide (MurNAc-GlcNAc)n. This reaction is
fueled by the hydrolysis of lipid II and by further hydrolysis of
the undecaprenolpyrophosphate product, which is translocated
across the plasma membrane into the cytoplasm (21). Linear
peptidoglycan strands are cross-linked by transpeptidases that
cleave murein pentapeptides (L-Ala-D-iGln-(NH2-Gly5)-L-Lys-D-
Ala-D-Ala) and synthesize an amide bond between the carboxyl
group of L-Ala-D-iGln-(NH2-Gly5)-L-Lys-D-Ala-COOH and the
amino group of pentaglycine cross-bridges (NH2-Gly5) within
neighboring peptidoglycan strands (22, 23). Together the trans-
glycosylation and transpeptidation reactions generate the
three-dimensional network of mature peptidoglycan, which in
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staphylococci contains less than 1% of free (non-cross-linked)
amino groups (NH2-Gly5) and glycan chains that are 12–60
sugar residues in length (24, 25).
Treatment of staphylococci with the strong nucleophile hy-
droxylamine releases surface protein acyl-intermediate from
sortase into the extracellular medium (8). The released surface
proteins bear a C-terminal threonine hydroxamate. These re-
sults suggest that the active site of sortase enzymes in staph-
ylococci may be generally occupied with cleaved polypeptides.
Thus, the rate-limiting step in surface protein anchoring ap-
pears to be the nucleophilic attack of the peptidoglycan sub-
strate that regenerates the active site sulfhydryl of sortase
(26). What is the peptidoglycan substrate that performs the
nucleophilic attack? Previous work addressed this question
using two experimental approaches. By following [35S]methi-
onine-labeled polypeptides over time, it was determined that
surface protein cleavage at the LPXTG motif occurred both in
intact bacteria and in staphylococcal protoplasts, cells in which
the peptidoglycan envelope had been removed by enzymatic
digestion (27). The second approach tested inhibitors of cell
wall synthesis for their effect on surface protein anchoring.
Vancomycin binds to the D-Ala-D-Ala moiety of lipid II (28, 29)
and prevents both transglycosylase and transpeptidase reac-
tions (30). In contrast, moenomycin is an inhibitor of transgly-
cosylation alone (31). Addition of vancomycin caused pepti-
doglycan synthesis inhibition and a steady accumulation of P2
precursor, indicating that this compound causes a reduction of
surface protein anchoring (27). A similar effect was observed
when moenomycin was added to staphylococcal cultures (27).
Together these results suggest that sortase utilizes a pepti-
doglycan precursor, but not mature assembled cell wall, as a
substrate for surface protein anchoring.
In this report we have labeled S. aureus cells with [32P]phos-
phoric acid and revealed the P3 intermediate of surface protein
anchoring. The P3 intermediate likely represents surface pro-
tein linked to lipid II and functions as a substrate for the
transglycosylation and transpeptidation reactions that incor-
porate surface protein into the peptidoglycan envelope.
EXPERIMENTAL PROCEDURES
Bacterial Strains, Plasmids, and Media—S. aureus RN4220 (sortase
wild-type) and its isogenic variant SKM1 (srtA:ermC) have been previ-
ously described (32, 33). Plasmid pHTT4 encodes Seb-MH6-Cws, an
engineered surface protein that has been characterized extensively in
structural analysis of cell wall anchoring (10). All chemicals were pur-
chased from Sigma Chemical Co. unless indicated otherwise.
Minimal medium lacking phosphate (MM-PO4) was generated by the
assembly of the following components: amino acid solution I (10:
threonine, serine, alanine, proline, valine, leucine, isoleucine, phen-
ylalanine, asparagine, glutamine, lysine, arginine, histidine, and gly-
cine at 1.2% each in water), amino acid solution II (20: aspartic acid,
glutamic acid, and tyrosine at 1% each in 0.4 M sodium hydroxide),
amino acid solution III (100: tryptophan at 1% in 0.2 M HCl), salt-PO4
solution (4: 4 g of ammonium sulfate, 2 g of sodium citrate  2H2O,
3.125 g of Tris-HCl, 400 mg of magnesium sulfate  7H2O, 40 mg of
ferrous sulfate  7H2O, water to 1 liter and pH 7.0), vitamin solution
(500: 500 mg of niacin, 25 mg of thiamine-HCl, and water to 0.1 liter),
glucose solution (50: 20% dextrose in water). To assemble 50 ml of
FIG. 1. The structure of S. aureus cell wall-anchored surface
protein and of the P3 intermediate. A, structure of surface protein
linked by an amide bond between the C-terminal threonine of the
LPXTG motif and the amino group of the pentaglycine cross-bridge.
Also shown is the structure of cross-linked peptidoglycan and the cleav-
age sites for lysostaphin (glycyl-glycine endopeptidase) and murami-
dase (MurNAc-(1–4)-GlcNAc). B, presumed structure of surface pro-
tein linked to lipid II (P3 precursor). Lysostaphin is expected to cleave
surface protein off lipid II, however, muramidase cannot cleave the P3
precursor structure.
FIG. 2. Incorporation of [35S]methionine and [3H]N-acetylglu-
cosamine into S. aureus surface protein. A, primary structure of
the surface protein precursor Seb-MH6-Cws, a fusion between entero-
toxin B (Seb) and C-terminal cell wall sorting signal (Cws) of protein A.
P1 precursor is directed across the cytoplasmic membrane by an N-
terminal leader peptide and is then cleaved by signal peptidase to
generate P2. P2 bears a C-terminal sorting signal that includes an
LPXTG motif, a hydrophobic domain (black bar) and positively charged
tail (boxed ). The sorting signal of P2 is cleaved at the LPXTG motif
and the mature protein (M) is linked to the cell wall. B, S. aureus
RN4220 (pHTT4) were pulse-labeled with [35S]methionine. At timed
intervals, i.e. 0.5, 1, 2, 5, and 10 min after the addition of an excess
unlabeled methionine, cells and proteins were precipitated with trichlo-
roacetic acid and the peptidoglycan was digested with lysostaphin.
Following immunoprecipitation, surface protein was separated on SDS-
PAGE and analyzed by phosphorimaging. C, S. aureus RN4220
(pHTT4) (protein A and Seb-MH6-Cws) were subjected to labeling with
[3H]GlcNAc followed by mutanolysin digestion of the cell wall, immu-
noprecipitation, SDS-PAGE, and PhosphorImager analysis. Some im-
munoprecipitated surface protein was digested with lysostaphin prior
to SDS-PAGE.
Lipid-II-linked Surface Proteins16242
 at CALIFO
RNIA INSTITUTE O
F TECHNO
LO
G
Y on Novem
ber 1, 2006 
w
w
w
.jbc.org
D
ow
nloaded from
 
MM-PO4, 28.4 ml of deionized water, 12.5 ml of 4 salt-PO4, 5 ml of
amino acid solution I, 2.5 ml of amino acid solution II, 0.5 ml of amino
acid solution III, 0.1 ml of vitamin solution, and 1 ml of dextrose
solution were mixed, warmed to 37 °C, and supplemented with 10 g/ml
chloramphenicol. Minimal medium (MM) with phosphate was gener-
ated as described for MM-PO4 and substituting the 4 salt-PO4 with
4 salt solution (4 g of ammonium sulfate, 2 g of sodium citrate 
2H2O, 8 g of potassium dihydrogen phosphate, 8 g of disodium hydrogen
phosphate, 400 mg of magnesium sulfate  7H2O, 40 mg of ferrous
sulfate  7H2O, deionized water to 1 liter and pH 7.5).
Labeling with [32P]Phosphoric Acid—S. aureus strains RN4220
(pHTT4) and SKM1 (pHTT4) were grown overnight in TSB supple-
mented with 10 g/ml chloramphenicol. Cultures (1 ml) were diluted
into 25 ml of fresh medium and grown with vigorous shaking for 3 h at
37 °C. Cultures were then centrifuged at 8000  g for 7 min. The
bacterial sediment was washed twice in an equal volume of MM-PO4
and suspended in a volume of MM-PO4 to yield an A600 1.2 and used
immediately for labeling experiments. Four milliliters of cells were
labeled by adding 200 Ci of [32P]phosphoric acid, mixed, and incubated
in a 37 °C water bath. At timed intervals (5, 30, 60, and 120 min), 1 ml
of cells was removed, transferred into an Eppendorf tube, and all
further incorporation of [32P]phosphoric acid into bacterial cell struc-
tures was quenched by the addition of 7.5% trichloroacetic acid and
incubation on ice for 30 min. Total cells and precipitated molecules were
collected by centrifugation at 16,000  g for 10 min, washed in ice-cold
acetone, precipitated by centrifugation at 16,000  g for 10 min, and
dried. Samples were suspended in 1 ml of 0.5 M Tris-HCl, pH 6.3, and
peptidoglycan was digested by adding 150 g of mutanolysin and incu-
bation for 4 h at 37 °C with intermittent mixing of samples. Mutanoly-
sin digests were precipitated by the addition of 7.5% trichloroacetic acid
and incubation on ice for 30 min. The precipitate was collected by
centrifugation at 16,000  g for 10 min, washed in ice-cold acetone,
precipitated by centrifugation at 16,000  g for 10 min and dried.
Samples were solubilized by boiling in 50 l of 0.5 M Tris-HCl, 4% SDS,
pH 8.0. 40-l samples were transferred to 1 ml of RIPA buffer (50 mM
Tris-HCl, 150 mM NaCl, 1% Triton X-100, 0.5% deoxycholate, 0.1% SDS,
pH 8.0) containing 1 l of rabbit -Seb antibodies. Antigen-antibody
complexes were captured on 50 l of pre-swollen protein A CL 4B-
Sepharose, washed five times with RIPA buffer and solubilized by
boiling in sample buffer. Immunoprecipitates were separated on 14%
SDS-PAGE, dried, and analyzed on PhosphorImager.
Labeling with [35S]Methionine—S. aureus strains RN4220 (pHTT4)
and SKM1 (pHTT4) were grown overnight in TSB supplemented with
10 g/ml chloramphenicol. Cultures (1 ml) were diluted into 25 ml of
fresh medium and grown with vigorous shaking for 3 h at 37 °C.
Cultures were then centrifuged at 8000  g for 15 min. The bacterial
sediment was washed twice in an equal volume of MM and suspended
in MM at A600 1.2 and used immediately for pulse labeling. 1 ml of cells
was labeled by adding 100 Ci of [35S]methionine, mixed, and incubated
in a 37 °C water bath. After 2 min of labeling, 50 l of chase solution
was added (100 mg/ml casamino acids, 10 mg/ml each of methionine
and cysteine) and at timed intervals (0, 1, 5, and 20 min after the chase),
250 l of cells was removed, transferred into an Eppendorf tube, and all
further processing of surface proteins was quenched by the addition of
7.5% trichloroacetic acid and incubation on ice for 30 min. Total cells
and precipitated molecules were collected by centrifugation at 16,000 
g for 10 min, washed in ice-cold acetone, precipitated by centrifugation
at 16,000  g for 10 min, and dried. Samples were suspended in 1 ml of
0.5 M Tris-HCl, pH 6.3, and peptidoglycan digested by adding 150 g
of mutanolysin and incubation for 4 h at 37 °C with intermittent mixing
of samples. Mutanolysin digests were precipitated by the addition of
7.5% trichloroacetic acid and incubation on ice for 30 min. (Some sam-
ples were directly digested with lysostaphin, i.e. 100 g of recombinant
lysostaphin and incubation for 1 h at 37 °C with intermittent mixing.)
The precipitate was collected by centrifugation at 16,000 g for 10 min,
washed in ice-cold acetone, precipitated by centrifugation at 16,000  g
for 10 min, and dried. Samples were solubilized by boiling in 50 l of 0.5
M Tris-HCl, 4% SDS, pH 8.0. 40-l samples were transferred to 1 ml of
RIPA buffer containing 1 l of rabbit -Seb antibodies. Antigen-anti-
body complexes were captured on 50 l of pre-swollen protein A CL
4B-Sepharose, washed five times with RIPA buffer, and solubilized by
boiling in sample buffer. Immunoprecipitates were separated on 14%
SDS-PAGE, dried, and analyzed on PhosphorImager.
Labeling with [3H]N-Acetylglucosamine—S. aureus strains RN4220
(pHTT4) was grown overnight in TSB supplemented with 10 g/ml
chloramphenicol. Cultures (1 ml) were diluted into 25 ml of fresh
medium and grown with vigorous shaking for 3 h at 37 °C. Cultures
were then centrifuged at 8000 g for 7 min. The bacterial sediment was
washed twice in an equal volume of MM and suspended in a volume of
MM to yield an A600 1.2 and used immediately for labeling experiments.
Three milliliters of cells were labeled by adding 150 Ci of [3H]GlcNAc,
mixed, and incubated in a 37 °C water bath. At timed intervals (30, 60,
and 120 min), 1 ml of cells was removed, transferred into an Eppendorf
tube, and all further incorporation of [3H]GlcNAc into bacterial cell
structures was quenched by the addition of 7.5% trichloroacetic acid
and incubation on ice for 30 min. Total cells and precipitated molecules
were collected by centrifugation at 16,000  g for 10 min, washed in
ice-cold acetone, precipitated by centrifugation at 16,000 g for 10 min,
and dried. Samples were suspended in 1 ml of 0.5 M Tris-HCl, pH 6.3,
and peptidoglycan was digested by adding 150 g of mutanolysin and
FIG. 3. Labeling S. aureus surface protein with [32P]phospho-
ric acid. A, S. aureus RN4220 (pHTT4), expressing protein A and
Seb-MH6-Cws, was labeled with either [
35S]methionine or [32P]phos-
phoric acid. Cells and proteins were precipitated with trichloroacetic
acid, and the peptidoglycan was digested with muramidase. Following
immunoprecipitation, surface proteins were either left untreated or cut
with lysostaphin and separated on SDS-PAGE and analyzed by phos-
phorimaging. B, S. aureus RN4220 (pHTT4) (protein A and Seb-MH6-
Cws) and S. aureus RN4220 (protein A but no Seb-MH6-Cws) were
subjected to labeling with [32P]phosphoric acid followed by immunopre-
cipitation, SDS-PAGE, and PhosphorImager analysis. As a control for
antibody specificity, samples were subjected to the same protocol with-
out added antiserum.
FIG. 4. Sortase is required for the biosynthesis of 32P-labeled
P3 intermediate. A, S. aureus RN4220 (pHTT4) and S. aureus SKM1
(srtA:ermC) (pHTT4) were subjected to labeling with [32P]phosphoric
acid followed by immunoprecipitation, SDS-PAGE, and Phosphor-
Imager analysis. Incorporation of 32P into S. aureus RN4220 (pHTT4)
and S. aureus SKM1 (srtA:ermC) (pHTT4) was determined by subject-
ing trichloroacetic acid-precipitated aliquots to liquid scintillation
counting (see Table I for quantification).
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incubation for 4 h at 37 °C with intermittent mixing of samples. Mu-
tanolysin digests were precipitated by the addition of 7.5% trichloro-
acetic acid and incubation on ice for 30 min. The precipitate was
collected by centrifugation at 16,000  g for 10 min, washed in ice-cold
acetone, precipitated by centrifugation at 16,000  g for 10 min, and
dried. Samples were solubilized by boiling in 50 l of 0.5 M Tris-HCl, 4%
SDS, pH 8.0. 40-l samples were transferred to 1 ml of RIPA buffer
containing 1 l of rabbit -Seb antibodies. Antigen-antibody complexes
were captured on 50 l of pre-swollen protein A CL 4B-Sepharose,
washed five times with RIPA buffer, and solubilized by boiling in
sample buffer. Immunoprecipitates were separated on 14% SDS-PAGE,
transferred to polyvinylidene difluoride, dried, and analyzed via tritium
screen on a PhosphorImager instrument.
Lysostaphin Digestion of Immunoprecipitated Surface Protein—After
washing immunoprecipitated samples with RIPA buffer, two washes
with 0.1 M Tris-HCl, pH 7.0, were added, and antigen antibody com-
plexes bound to protein A-Sepharose beads were suspended in 1 ml of
0.1 M Tris-HCl, pH 7.0, with 200 g of lysostaphin and incubated for 1 h.
After another round of washing in RIPA buffer, the antigen/antibody
complexes were disrupted by boiling in sample buffer and separated on
14% SDS-PAGE.
Inhibition of Surface Protein Anchoring in S. aureus Cultures—
S. aureus RN4220 (pHTT4) was grown overnight in TSB supplemented
with 10 g/ml chloramphenicol. Cultures (1 ml) were diluted into 25 ml of
fresh medium supplemented and grown with vigorous shaking for 30 min
at 37 °C. At this time, 10 g/ml penicillin G, 10 g/ml vancomycin, 10
g/ml moenomycin, 20 g/ml bacitracin, or 15 g/ml tunicamycin were
added, and the cultures were grown with vigorous shaking for an addi-
tional 150 min at 37 °C. The A600 was recorded at timed intervals, and
washed cells were suspended in small volumes to achieve labeling of 1.2
A600 units of cells with [
32P]phosphoric acid.
Measuring the Incorporation of Radiolabel by S. aureus Cultures—To
determine the amount of incorporated radiolabel, trichloroacetic acid
precipitated, and acetone washed samples (after mutanolysin or lyso-
staphin digestion) were suspended in 50 l of 0.5 M Tris-HCl, 4% SDS,
pH 8.0, and 2-l aliquots were subjected to scintillation counting.
Immunoblotting—Mutanolysin-digested and trichloroacetic acid pre-
cipitated cell extracts were suspended by boiling in 50 l of 0.5 M
Tris-HCl, 4% SDS, pH 8.0. An equal amount of sample buffer was
added, and samples were heated to 95 °C. for 10 min, 10-l aliquots
were separated on SDS-PAGE and electrotransferred onto polyvinyli-
dene difluoride membranes (Millipore). The membrane filter was
blocked in 20 ml of TBS-M (20 mM Tris-HCl, 20 mM NaCl, 0.1% Tween
20, pH 7.5, and 5% dried skim milk). The filter was washed in TBS-T
(TBS-M without milk) and incubated for 1 h with a 1:20,000 dilution of
monoclonal antibody SPA-27 in 20 ml of TBS-M. The filter was again
washed three times in TBS-T and incubated for 45 min with a 1:5000
diluted secondary antibody (anti-mouse conjugated to horseradish per-
oxidase). Immunoreactive signals were developed with a chemilumines-
cent substrate using an AlphaImager.
Thin-layer Chromatography—[32P]Phosphoric acid-labeled surface
protein was immunoprecipitated from mutanolysin-digested staphylo-
cocci. After five washes with RIPA buffer, the charged protein A CL-
4B-Sepharose beads were pooled, washed with 0.1 mM Tris-HCl (pH
7.0), and dispensed into aliquots. After removal of the buffer, samples
were incubated for 1 h at 37 °C by: (i) mock treatment with 20 l of 25
mM Tris-HCl, pH 7.0, or (ii) treatment with 8 g of lysostaphin in 25 mM
Tris-HCl, pH 7.0. To measure the formation of a complex between
32P-labeled cell wall anchor structures and nisin, 20 l of lysostaphin-
digested sample was mixed with 20 l of mock mix (644.8 l of water,
100 l of 1 M Tris-HCl, pH 8.8, 116 l of 1 M MgCl2, 23.2 l of 1 M NH4Cl,
116 l of 0.1 M SDS) or 20 l of nisin mix (624.8 l of water, 100 l of
1 M Tris-HCl, pH 8.8, 116 l of 1 M MgCl2, 23.2 l of 1 M NH4Cl, 116 l
of 0.1 M SDS, 20 l of nisin, 80 mg/ml water). Reactions were incubated
at 25 °C for 1.5 h. For TLC analysis, 2-l aliquots were spotted onto K6
silica plates and separated 7 cm using one of two solvents: solvent A is
isobutyric acid and 1 N NH4OH (5:3, v/v); solvent B is n-butanol, acetic
acid, water, pyridine (15:3:12:10, v/v). Silica gels were dried and placed
on PhosphorImager screens for 3 days.
RESULTS
[32P]Phosphoric Acid-labeled Surface Protein—An earlier
model for the cell wall-anchoring reaction predicted the exist-
ence of the P3 intermediate, a compound in which surface
protein is amide-linked to the cross-bridge of lipid II (10) (Fig.
1). However, pulse-labeling experiments with [35S]methionine
revealed processing of P1 and P2 precursors to mature an-
chored surface protein but failed to detect the P3 intermediate
(Fig. 2, A and B). During the course of these experiments the
cell wall envelope of staphylococci was treated with lyso-
staphin, a glycyl-glycine endopeptidase that cleaves S. aureus
cross-bridges (34), thereby solubilizing P1, P2, and mature
surface protein. Close examination of the structure of the pre-
sumed P3 intermediate and of mature surface protein revealed
that both compounds contain pentaglycine cross-bridges as an-
choring points for surface proteins (Fig. 1). Thus, after cleavage
FIG. 5. Antibiotic inhibition of peptidoglycan synthesis and
surface protein display. A, S. aureus RN4220 (pHTT4) cells were
diluted into fresh TSB medium containing either 10 g/ml chloram-
phenicol and no antibiotic (1), 20 g/ml bacitracin (2), 10 g/ml peni-
cillin (3), 10 g/ml vancomycin (4), or 10 g/ml moenomycin (5). At
timed intervals, the cell density of culture aliquots was determined as
the A600. B, culture aliquots obtained after 150 min of antibiotic inhi-
bition were precipitated with trichloroacetic acid, and the peptidoglycan
was digested with muramidase. Aliquots were separated on SDS-PAGE
and analyzed by immunoblotting with protein A-specific monoclonal
antibody (-SPA27). One culture aliquot of staphylococci that were
grown in the absence antibiotics was treated for 5 min with MTSET, a
known inhibitor of sortase.
TABLE I
Sortase is required for the synthesis of surface protein P3 precursor
Data were obtained and quantified from Fig. 4.
Surface protein
32P-Surface protein P3/total cellular 32P
concentration
5 mina 30 min 60 min 120 min
Wild-typeb
Protein A 5 43 39 27
Seb-MH6-Cws 0 14 12 9
srtAc
Protein A 0 2 2 2
Seb-MH6-Cws 0 1 1 1
a Time after the addition of [32P]phosphoric acid to S. aureus RN4220
(pHTT4) culture at which labeling was quenched with ice-cold trichlo-
roacetic acid.
b S. aureus RN4220.
c S. aureus SKM1 (srtA).
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with lysostaphin, it is impossible to distinguish P3 precursor
and mature surface protein because both species display the
same compound structure and mass. Mutanolysin, an N-acetyl-
muramidase that cuts the 1–4 glycosidic bond between Mur-
NAc-GlcNAc, cleaves the glycan strands of mature peptidogly-
can but does not cut lipid II or surface protein linked to lipid II
(35). Mutanolysin-released surface protein migrates as a large
spectrum of fragments on SDS-PAGE, a phenomenon that pre-
cludes the identification of [35S]methionine-labeled P3 precur-
sors with discrete mass (4) (Fig. 3).
Mature surface protein is linked to peptidoglycan, a polymer
that contains the repeating disaccharide MurNAc-GlcNAc.
Staphylococcal cultures were labeled with [3H]GlcNAc. Bacte-
ria were isolated and their cell walls digested with mutanoly-
sin. Surface protein was immunoprecipitated and analyzed by
SDS-PAGE and PhosphorImager after amplification of the trit-
ium signal (Fig. 2C). A spectrum of [3H]GlcNAc-labeled protein
A and Seb-MH6-Cws molecules with linked cell wall fragments
was detected. Lysostaphin digestion of the mutanolysin-re-
leased and immunoprecipitated surface protein removed all
[3H]GlcNAc, indicating that polypeptides were indeed linked to
peptidoglycan. (The single radioactive band in Fig. 2C is caused
by the compression of IgG heavy chains and represents an
artifact of immunoprecipitation.) As the products of the sorting
reaction, i.e. cell wall-anchored surface protein, are far more
abundant than the P3 precursor species, it appears that alter-
native labeling techniques are needed to demonstrate the for-
mation of lipid II-linked surface protein.
Previous work achieved labeling of S. aureus undecaprenol-
phosphate, lipid I, and lipid II with [32P]phosphoric acid (36, 37)
(see Fig. 1. for a structure of lipid II). We reasoned that [32P]phos-
phoric acid labeling of staphylococci may allow incorporation of
[32P] into surface protein P3 precursor species. Because lipid II is
the only extracellular peptidoglycan precursor that is known to
harbor phosphate (38), isolation of 32P-labeled surface protein
would provide strong evidence for the linkage of polypeptides to
lipid II. To test this prediction, S. aureus RN4220 (pHTT4), a
strain expressing the immunoglobulin binding protein A (39) and
Seb-MH6-Cws (an engineered surface protein encoded on
pHTT4), was grown in TSB. The cells were collected by centrif-
ugation, washed, and suspended in minimal medium lacking
phosphate. After adding [32P]phosphoric acid for various
amounts of time, labeling was quenched by precipitating all
proteins with ice-cold trichloroacetic acid. The cell walls of staph-
ylococci were digested with mutanolysin. Protein A and Seb-
MH6-Cws were immunoprecipitated with specific antibody, sep-
arated on SDS-PAGE, and detected by PhosphorImager. This
approach revealed two 32P-labeled surface protein species, mi-
grating on SDS-PAGE with a mass of 44 and 54 kDa (Fig. 3A).
Labeling with [35S]methionine followed by muramidase digestion
and immunoprecipitation identified cell wall-anchored protein A
and Seb-MH6-Cws, each of which migrated as a spectrum of
fragments with linked peptidoglycan (4). We sought to obtain
definitive proof for the notion that the faster migrating species
represented [32P]Seb-MH6-Cws, whereas the slower migrating
species represented [32P]protein A. [32P]Phosphoric acid labeling
of S. aureus RN4220 without pHTT4 (no Seb-MH6-Cws) and
immunoprecipitation resulted in the appearance of the 54-kDa
species but not of the 44-kDa species (Fig. 3B). Furthermore,
omission of antibodies from the immunoprecipitation reaction of
[32P]phosphoric acid-labeled S. aureus RN4220 (pHTT4) failed to
generate the two discrete 32P-labeled protein species. Thus, the
44- and the 54-kDa species very likely represent [32P]Seb-MH6-
Cws and [32P]protein A, respectively.
[32P]Phosphoric Acid-labeled P3 Intermediates—If the 32P-
labeled species reported in Fig. 3A represent the P3 interme-
FIG. 6. Antibiotic inhibition of the biosynthesis of 32P-labeled
P3 intermediate. A, S. aureus RN4220 (pHTT4) cells were diluted into
fresh TSB medium containing either 10 g/ml chloramphenicol and no
antibiotic (no inhibitor), penicillin, vancomycin, moenomycin, or baci-
tracin. 4 ml of cells was labeled with [32P]phosphoric acid for 5, 30, 60,
and 120 min. At timed intervals, 1-ml samples were precipitated with
trichloroacetic acid, digested with muramidase, and analyzed by immu-
noprecipitation, SDS-PAGE, and phosphorimaging. The sortase inhib-
itor MTSET was added shortly after labeling with [32P]phosphoric acid.
FIG. 7. Tunicamycin inhibits the formation of 32P-labeled P3
intermediate. A, S. aureus RN4220 (pHTT4) cells were diluted into
fresh TSB medium containing either 10 g/ml chloramphenicol and no
antibiotic () or tunicamycin (). 4 of cells was labeled with [32P]phos-
phoric acid for 5, 30, 60, and 120 min. At timed intervals, 1-ml samples
were precipitated with trichloroacetic acid, digested with muramidase,
and analyzed by immunoprecipitation, SDS-PAGE, and phosphor-
imaging.
TABLE II
Bacitracin inhibits the synthesis of surface protein P3 precursor
Data were obtained and quantified from Fig. 6.
Surface protein
32P-Surface protein P3/total cellular 32P
concentration
5 mina 30 min 60 min 120 min
No inhibitor
Protein A 7 10 28 19
Seb-MH6-Cws 1 6 11 9
Bacitracin
Protein A 0 2 1.5 11
Seb-MH6-Cws 0 1 1 7
a Time after the addition of [32P]phosphoric acid to S. aureus RN4220
(pHTT4) culture at which labeling was quenched with ice-cold trichlo-
roacetic acid.
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diate of surface protein anchoring to the cell wall envelope, one
can test this assumption in two ways. (i) The structure of this
compound (Fig. 1B) predicts that treatment of 32P-labeled P3
intermediate with lysostaphin, but not with muramidase,
should remove the 32P-label from surface protein. This was
tested by first immunoprecipitating surface proteins and then
treating the sample with lysostaphin. Lysostaphin digestion
converted all [35S]methionine-labeled, muramidase-solubilized
surface protein to a faster mobility, consistent with the previ-
ously reported removal of C-terminal cell wall anchor struc-
tures (12) (Fig. 3A). In contrast, lysostaphin digestion of 32P-
labeled surface protein removed all radioactive signal from the
immunoprecipitated polypeptides (Fig. 3A). (ii) The second pre-
diction is that 32P-labeling of P3 precursors should be abso-
lutely dependent on sortase and S. aureus mutants lacking srtA
sortase should fail to incorporate 32P-label into surface protein
(Fig. 4). Indeed, [32P]phosphoric acid labeling of S. aureus
RN4220 (pHTT4) generated the 44- and 54-kDa species,
whereas labeling of S. aureus SKM1 (srtA) (pHTT4) did not
yield a radioactive surface protein signal (Fig. 4 and Table I).
Both strains, S. aureus RN4220 (pHTT4) and S. aureus SKM1
[(srtA)] (pHTT4), incorporated equal amounts of [32P]phos-
phoric acid into cells as judged by liquid scintillation counting
of trichloroacetic acid precipitated aliquots. Thus, both of our
tests fulfilled the predictions that would be expected for 32P-
labeled surface proteins linked to lipid II.
Antibiotic Inhibition of P3 Precursor Synthesis—Several an-
tibiotics are known interfere with the synthesis of the bacterial
peptidoglycan. The addition of such compounds may block sor-
tase-mediated biosynthesis of P3 intermediate from P2 precur-
sor and lipid II as substrates. Our experimental approach used
S. aureus cultures that were treated for 150 min with penicil-
lin, vancomycin, bacitracin, or moenomycin. Vancomycin and
moenomycin are known inhibitors of the sorting reaction. Van-
comycin binds to the D-Ala-D-Ala moiety of lipid II (28, 29) and
prevents both transglycosylase and transpeptidase reactions
(30), whereas moenomycin is an inhibitor of transglycosylation
alone (31). Penicillin is an inhibitor of the transpeptidation
reaction (38). Bacitracin inhibits undecaprenolpyrophosphate
dephosphorylation, an essential step in the recycling of lipid II
(40). As is shown in Fig. 5A, the addition of antibiotics slowed
bacterial growth and inhibited bacterial cell wall synthesis
(27). Equal numbers of staphylococcal cells from each sample
were washed, suspended in minimal medium lacking phos-
phate, and labeled with [32P]phosphoric acid. To account for the
presence of surface protein in each sample, we subjected mur-
amidase-treated samples to SDS-PAGE and immunoblotting
with monoclonal antibody -SPA27 (protein A-specific). As is
shown in Fig. 5B, treatment of staphylococci with penicillin,
vancomycin, bacitracin, or moenomycin led to a significant
reduction in the amount of protein A incorporated into the cell
wall. Vancomycin and moenomycin caused the largest decrease
in surface protein anchoring and display, consistent with pre-
vious reports that these antibiotics prevent the incorporation of
polypeptides into the cell wall envelope (27, 41).
Treatment of staphylococci with penicillin, vancomycin, or
moenomycin abolished the biosynthesis of P3 intermediate
(Fig. 6, A and B). Bacitracin treatment caused a significant
reduction in the synthesis of P3 intermediates at all labeling
points examined (Fig. 6B and Table II). We also tested a known
inhibitor of sortase for its effect on the P3 biosynthetic reaction.
Staphylococci were treated with MTSET, a reagent that forms
disulfide with the active site sulfhydryl of sortase (8). MTSET
treatment abolished all P3 biosynthesis. Together these data
indicated that the inhibition of both sortase or cell wall biosyn-
thesis prevented P3 precursor formation and the anchoring of
surface proteins to the cell wall envelope (27).
Tunicamycin (42), a lipid-linked nucleotide, acts as an inhib-
itor of phospho-N-acetylmuramyl-pentapeptide translocase, an
enzyme that synthesizes lipid I (undecaprenolpyrophosphate-
MurNAc-L-Ala-D-iGln-(NH2)-L-Lys-D-Ala-D-Ala) from Park’s
nucleotide (43–45). Tunicamycin treatment is expected to in-
hibit the formation of the P3 precursor as this antibiotic de-
pletes bacteria of both lipid I and lipid II. Indeed, tunicamycin
treatment abolished the formation of 32P-labeled P3 interme-
diate, strongly supporting the hypothesis that P3 may be com-
posed of surface protein linked to lipid II (undecaprenolpyro-
phosphate-MurNAc-(L-Ala-D-iGln-(surface protein-Gly5)-L-Lys-
D-Ala-D-Ala)-(1–4)-GlcNAc) (Fig. 7 and Table III).
TLC Analysis of 32P-Labeled Cell Wall Anchor Molecules—
Undecaprenyl pyrophosphate is not abundant in staphylococci
(less than 1000 molecules in a single bacterium) (46). It seemed
improbable that one could achieve isolation of 32P-labeled P3
intermediate in sufficient quantity for mass spectrometry ex-
periments, assuming that the P3 species represents only a
FIG. 8. Lysostaphin released 32P-labeled anchor species bind
to nisin. Immunoprecipitated 32P-labeled surface protein was either
left untreated (mock) or was incubated with lysostaphin. Samples were
subjected to thin layer chromatography of K6 silica gel plates using
solvent A. After separation for 7 cm, the plates were dried and analyzed
by PhosphorImager analysis. In separate reactions, lysostaphin-treated
[32P]P3 intermediates were either mock treated or incubated with nisin,
a lantibiotic that is known to bind lipid II. Binding of nisin to lipid II
prevents migration of the sample on TLC plates.
TABLE III
Tunicamycin inhibits the synthesis of surface protein P3 precursor
Data were obtained and quantified from Fig. 7.
Surface protein
32P-Surface protein P3/total cellular 32P
concentration
5 mina 30 min 60 min 120 min
No inhibitor
Protein A 7 53 36 82
Seb-MH6-Cws 11 46 22 51
Tunicamycin
Protein A 0 0 0 22
Seb-MH6-Cws 0 0 0 14
a Time after the addition of [32P]phosphoric acid to S. aureus RN4220
(pHTT4) culture at which labeling was quenched with ice-cold trichlo-
roacetic acid.
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small fraction of undecaprenol molecules (less than 1%) that
are engaged in cell wall and carbohydrate biosynthetic path-
ways (46). TLC is an alternative method for the analysis of
32P-labeled cell wall anchor structures, because the use of
organic solvents on silica plates provides for the separation of
lipid but not of larger polypeptides (47). Immunoprecipitated
32P-labeled P3 intermediate was spotted on K6 silica TLC
plates, separated with isobutyric acid: 1 N NH4OH (5:3, solvent
A) and analyzed by phosphorimaging. 32P-Labeled P3 interme-
diate generated a robust radioactive signal (70,000 Phospho-
rImager counts). Most of the 32P-label was retained at the site
of loading, consistent with the expectation that surface pro-
teins cannot migrate with the solvent on the K6 matrix (Fig. 8)
(47). Moreover, a second 32P-signal could be detected near the
solvent front (Fig. 8).
It was presumed that 32P-labeled anchor species entering the
TLC plate may represent lipid II molecules spontaneously re-
leased from surface protein. If so, one would predict that the
release of 32P-labeled anchor species must be increased by the
treatment of surface protein with lysostaphin. This was tested,
and lysostaphin treatment greatly diminished the radioactive
signal at the migrational start while causing a corresponding
increase in the amount of 32P-labeled anchor species. To deter-
mine whether or not the 32P-labeled anchor species represent
lipid II molecules, we exploited the affinity of the lantibiotic
nisin for lipid II (48–50). Previous work showed that the bind-
ing of nisin to lipid II resulted in the formation of immobile
complexes on TLC (48). Incubation of 32P-labeled anchor spe-
cies with nisin also resulted in the formation of chromatograph-
ically immobile complexes (Fig. 8). This experiment was re-
peated using two different solvents for the separation of lipids.
Solvent A released only small amounts of 32P-labeled cell wall
anchor structures from immunoprecipitated surface protein. In
contrast, solvent B (n-butanol:acetic acid:water:pyridine, 15:3:
12:10, v/v) was much more effective in removing 32P-labeled
anchor structures from surface protein, even in the absence of
lysostaphin treatment. Nisin is known to form a complex with
lipid II even under the stringent conditions of solvent B (48). A
similar interaction was observed with 32P-labeled anchor spe-
cies, because the addition of nisin to lysostaphin-digested sur-
face protein led to the formation of immobile, 32P-labeled com-
plexes on TLC (Table IV). In summary, incubation with nisin
inhibited the migration of 32P-labeled anchor structures 9-fold
in solvent A and 20- to 7-fold in solvent B (Table IV). These
data strongly suggest that the 32P-labeled anchor species bind
to nisin and, furthermore, that the 32P-labeled P3 intermediate
represents surface protein linked to lipid II.
DISCUSSION
Several recent studies focused on characterizing the pepti-
doglycan substrate of the sortase-catalyzed anchoring reaction.
By measuring the processing of pulse-labeled surface proteins,
it was determined that both whole cells and staphylococcal
protoplasts are capable of anchoring surface proteins (27). Fur-
thermore, antibiotic inhibition of de novo bacterial peptidogly-
can synthesis inhibits surface protein anchoring (27). Both
results are consistent with the view that sortase utilizes the
peptidoglycan precursor lipid II but not mature assembled cell
walls as substrates for its transpeptidation reaction (2). An-
other argument in favor of lipid II is the notion that the amide
bond between the threonine and the glycine of surface proteins
is identical for the substrate (LPXTG motif) and the product
(LPXT-Gly5) of the sorting reaction. Thus, if sortase were to
interact with assembled peptidoglycan and if sortase catalyzed
both forward and reverse transpeptidation reactions, the en-
zyme would in fact cut cell wall-anchored surface protein. This
notion is not supported by our in vivo labeling experiments,
revealing that sortase rapidly and efficiently anchors surface
proteins to the cell wall (3). We presume that surface protein
linked to lipid II is rapidly incorporated into the cell wall and
that this mechanism prevents sortase from catalyzing a revers-
ible reaction.
Purified sortase catalyzes an in vitro transpeptidation reac-
tion of surface protein anchoring using LPXTG peptides and
NH2-Gly, NH2-Gly2, NH2-Gly3, NH2-Gly4, or NH2-Gly5 as pep-
tidoglycan substrates (26). Previous work used in vitro as well
as in vivo techniques to determine that the pentaglycine cross-
bridges (NH2-Gly5) are better substrates than shorter cross-
bridges for the sorting reaction (11, 26). However, this work
still left unresolved whether murein tetra- or pentapeptides
with or without linked undecaprenol and disaccharide (lipid II)
are the preferred substrate for the in vitro sorting reaction. To
identify the peptidoglycan substrate of the sorting reaction in
vivo we entertained the possibility that surface proteins can be
labeled with [32P]phosphoric acid to generate the P3 interme-
diate. Such a species could indeed be observed. The following
arguments suggest that P3 intermediates represent surface
protein linked to lipid II. (i) 32P-Labeled surface protein (44
kDa) migrates more slowly than the 35S-labeled mature species
(30 kDa). The predicted mass of the P3 precursor is about 33
kDa. Assuming that undecaprenolpyrophosphate does not sep-
arate on SDS-PAGE in the same manner as polypeptides with-
out lipid decoration, the slower mobility of P3 suggest that lipid
is indeed attached to surface protein. (ii) The 32P-label of sur-
face proteins can be removed by lysostaphin digestion but not
by muramidase treatment. (iii) The formation of 32P-labeled P3
precursor absolutely requires sortase as treatment with MT-
SET or deletion of the sortase gene abolishes its appearance.
(iv) Inhibition of peptidoglycan synthesis with antibiotics in-
terferes with the biosynthesis of 32P-labeled P3 precursor. (v)
Lysostaphin treatment of P3 intermediates results in the re-
lease of 32P-labeled anchor species that can be separated on
TLC plates. (vi) Nisin, a lantibiotic that is known to bind lipid
II, also forms a complex with 32P-labeled anchor species. To-
gether these data suggest that 32P-labeled P3 precursor likely
represents surface protein linked to lipid II. It is anticipated
that P3 intermediates are present in very small numbers in
living cells, because lipid I and lipid II molecules are the least
abundant intermediates of peptidoglycan biosynthesis (46). It
seems certain that the purification and analysis strategies
established for surface proteins anchored to cell wall can not be
used for the isolation of P3 (10).
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